EMEA-003151-PIP01-21 - paediatric investigation plan

Indapamide
Telmisartan
PIPHuman

Key facts

Active Substance
  • Indapamide
  • Telmisartan
Therapeutic area
Cardiovascular diseases
Decision number
P/0111/2022
PIP number
EMEA-003151-PIP01-21
Pharmaceutical form(s)
Modified-release tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries

KRKA, d.d., Novo mesto

 +386 73312657

stasa.taferner@krka.biz

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page